Table of Content

1 INTRODUCTION 50
1.1 OBJECTIVES OF THE STUDY 50
1.2 MARKET DEFINITION & SCOPE 50
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 51
1.2.2 MARKET SEGMENTATION 52
FIGURE 1 BIOSURGERY MARKET SEGMENTATION 52
1.2.3 YEARS CONSIDERED FOR THE STUDY 53
1.3 CURRENCY 53
1.4 STAKEHOLDERS 54
1.5 SUMMARY OF CHANGES 54
2 RESEARCH METHODOLOGY 56
2.1 RESEARCH APPROACH 56
2.2 RESEARCH METHODOLOGY DESIGN 56
2.2.1 SECONDARY RESEARCH 56
2.2.1.1 Key data from secondary sources 57
2.2.2 PRIMARY DATA 58
FIGURE 2 PRIMARY SOURCES 58
2.2.2.1 Key data from primary sources 59
2.2.2.2 Insights from primary experts 59
2.2.2.3 Breakdown of primary interviews: Supply-side and demand-side participants 60
2.2.2.4 Breakdown of primary interviews: By company, designation, and region 60
2.3 MARKET SIZE ESTIMATION: BIOSURGERY MARKET 61
FIGURE 3 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 61
FIGURE 4 REVENUE SHARE ANALYSIS ILLUSTRATION?BAXTER INTERNATIONAL, INC. 62
FIGURE 5 REVENUE ANALYSIS OF THE TOP 3 PUBLIC COMPANIES: SURGICAL SEALANTS AND ADHESIVES SEGMENT (2020) 63
FIGURE 6 BOTTOM-UP APPROACH?SEGMENTAL EXTRAPOLATION 64
FIGURE 7 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE BIOSURGERY MARKET
(2021–2026) 65
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 67
2.5 MARKET SHARE ESTIMATION 67
2.6 ASSUMPTIONS FOR THE STUDY 68
2.7 LIMITATIONS 68
2.7.1 METHODOLOGY-RELATED LIMITATIONS 68
2.8 RISK ASSESSMENT 69
TABLE 1 RISK ASSESSMENT: BIOSURGERY MARKET 69
3 EXECUTIVE SUMMARY 70
FIGURE 10 BIOSURGERY MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 70
FIGURE 11 BIOSURGERY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 71
FIGURE 12 BIOSURGERY MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 72
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE BIOSURGERY MARKET 73
4 PREMIUM INSIGHTS 74
4.1 BIOSURGERY MARKET OVERVIEW 74
FIGURE 14 INCREASING NEED TO MANAGE BLOOD LOSS IN PATIENTS AND FOCUS ON THE LAUNCH OF NEW PRODUCTS TO DRIVE MARKET GROWTH 74
4.2 ASIA PACIFIC: BIOSURGERY MARKET FOR NATURAL SEALANTS & ADHESIVES,
BY TYPE AND COUNTRY (2020) 75
FIGURE 15 FIBRIN-BASED SEALANTS & ADHESIVES SEGMENT ACCOUNTED FOR
THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2020 75
4.3 BIOSURGERY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 76
FIGURE 16 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING
THE FORECAST PERIOD 76
4.4 BIOSURGERY MARKET, BY REGION (2019–2026) 77
FIGURE 17 NORTH AMERICA WILL CONTINUE TO DOMINATE THE BIOSURGERY MARKET DURING THE FORECAST PERIOD 77
4.5 BIOSURGERY MARKET: DEVELOPED VS. DEVELOPING MARKETS 77
FIGURE 18 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING
THE FORECAST PERIOD 77
5 MARKET OVERVIEW 78
5.1 INTRODUCTION 78
5.2 MARKET DYNAMICS 78
5.2.1 MARKET DRIVERS 79
5.2.1.1 Increasing volume of surgeries and growing prevalence of severe trauma injuries 79
TABLE 2 UK: INCREASE IN THE NUMBER OF CARDIAC SURGICAL PROCEDURES PERFORMED 79
5.2.1.2 Strong focus on R&D leading to the launch of technologically advanced products 80
5.2.1.3 Rising need for effective blood loss management in patients 81
5.2.2 MARKET RESTRAINTS 81
5.2.2.1 High price of biosurgery products and the rising cost of surgical procedures 81
5.2.3 MARKET OPPORTUNITIES 82
5.2.3.1 Growing use of combination materials for enhancing product efficacy 82
5.2.3.2 Growing adoption of advanced biosurgery products in emerging markets 82
TABLE 3 COST OF SURGICAL PROCEDURES: US VS. INDIA (USD) 83
5.2.3.3 Growing adoption of adhesive dentistry procedures 83
5.2.4 MARKET CHALLENGES 84
5.2.4.1 Stringent regulatory framework 84
5.2.4.2 Requirement of skilled personnel for the effective use of biosurgery products 84
6 INDUSTRY INSIGHTS 86
6.1 INTRODUCTION 86
6.2 INDUSTRY TRENDS 86
6.2.1 GROWING FOCUS ON ORGANIC GROWTH STRATEGIES 86
TABLE 4 NUMBER OF PRODUCT LAUNCHES BY KEY PLAYERS (JANUARY 2018 TO JUNE 2021) 86
6.2.2 GROWING DEMAND FOR DENTAL BONE-GRAFT SUBSTITUTES 87
6.2.3 GROWING PREFERENCE FOR GELATIN-BASED ADHESIVES & HYDROGELS IN SURGICAL PROCEDURES 87
6.2.4 USE OF NANOTECHNOLOGY FOR DEVELOPING NEXT-GENERATION ADHESIVES 88
6.3 REGULATORY ANALYSIS 89
TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING BIOSURGERY PRODUCTS 89
6.3.1 NORTH AMERICA 89
6.3.1.1 US 89
TABLE 6 US FDA: CLASSIFICATIONS OF MEDICAL DEVICES 90
FIGURE 19 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES 91
6.3.1.2 Canada 91
FIGURE 20 CANADA: CLASS III MEDICAL DEVICES APPROVAL PROCESS 91
6.3.2 EUROPE 92
FIGURE 21 EUROPE: CE APPROVAL PROCESS FOR BIOSURGERY PRODUCTS 92
6.3.3 ASIA PACIFIC 92
6.3.3.1 Japan 92
TABLE 7 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY 93
6.3.3.2 China 93
TABLE 8 NMPA MEDICAL DEVICES CLASSIFICATION 93
6.3.3.3 India 94
TABLE 9 INDIA: CLASSIFICATION OF BIOSURGERY PRODUCTS 94
6.4 PORTER’S FIVE FORCES ANALYSIS 94
TABLE 10 PORTER’S FIVE FORCES ANALYSIS 94
6.4.1 THREAT OF NEW ENTRANTS 95
6.4.2 THREAT OF SUBSTITUTES 95
6.4.3 BARGAINING POWER OF SUPPLIERS 95
6.4.4 BARGAINING POWER OF BUYERS 95
6.4.5 INTENSITY OF COMPETITIVE RIVALRY 96
6.5 PRICING ANALYSIS 96
TABLE 11 AVERAGE SELLING PRICE FOR BIOSURGERY PRODUCTS 97
6.6 TECHNOLOGY ANALYSIS 97
6.7 ECOSYSTEM ANALYSIS 98
FIGURE 22 BIOSURGERY MARKET: ECOSYSTEM ANALYSIS 98
6.8 VALUE CHAIN ANALYSIS 98
FIGURE 23 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING
THE MANUFACTURING PHASE 99
6.9 PATENT ANALYSIS 99
6.9.1 PATENT PUBLICATION TRENDS FOR BIOSURGERY 99
FIGURE 24 PATENT PUBLICATION TRENDS (JANUARY 2011–JUNE 2021) 100
6.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS 100
FIGURE 25 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR BIOSURGERY PATENTS (JANUARY 2011 TO JUNE 2021) 101
FIGURE 26 TOP APPLICANT COUNTRIES/REGIONS FOR BIOSURGERY PATENTS
(JANUARY 2011 TO JUNE 2021) 102
TABLE 12 LIST OF FEW PATENTS IN THE BIOSURGERY MARKET, 2020–2021 102
6.10 COVID-19 IMPACT ON THE BIOSURGERY MARKET 103
7 BIOSURGERY MARKET, BY PRODUCT 105
7.1 INTRODUCTION 106
TABLE 13 BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 106
7.2 BONE-GRAFT SUBSTITUTES 106
TABLE 14 BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE,
2019–2026 (USD MILLION) 107
TABLE 15 BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY COUNTRY,
2019–2026 (USD MILLION) 107
7.2.1 DEMINERALIZED BONE MATRIX 108
7.2.1.1 DBM is used extensively as a void filler in joint reconstruction and spinal fusion procedures 108
TABLE 16 MAJOR PRODUCTS IN THE DBM MARKET 108
TABLE 17 DEMINERALIZED BONE MATRIX MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 109
7.2.2 SYNTHETIC BONE GRAFTS 109
7.2.2.1 Development of standard materials for synthetic bone grafts to drive the growth of this market segment 109
TABLE 18 MAJOR PRODUCTS IN THE SYNTHETIC BONE GRAFTS MARKET 110
TABLE 19 SYNTHETIC BONE GRAFTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 111
7.2.3 BONE MORPHOGENETIC PROTEINS 111
7.2.3.1 Regulatory approval for the use of BMP in spinal fusion procedures to drive the growth of this market segment 111
TABLE 20 MAJOR PRODUCTS IN THE BONE MORPHOGENETIC PROTEINS MARKET 112
TABLE 21 BONE MORPHOGENETIC PROTEINS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 112
7.2.4 OTHER BONE-GRAFT SUBSTITUTES 113
TABLE 22 MAJOR PRODUCTS IN THE OTHER BONE-GRAFT SUBSTITUTES MARKET 114
TABLE 23 OTHER BONE-GRAFT SUBSTITUTES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 114
?
7.3 SOFT-TISSUE ATTACHMENTS 115
TABLE 24 BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE,
2019–2026 (USD MILLION) 115
TABLE 25 BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY COUNTRY, 2019–2026 (USD MILLION) 116
7.3.1 SYNTHETIC MESHES 116
7.3.1.1 Vendors are focusing on developing new composite synthetic meshes to gain a competitive edge 116
TABLE 26 MAJOR PRODUCTS IN THE SYNTHETIC MESHES MARKET 117
TABLE 27 SYNTHETIC MESHES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 118
7.3.2 BIOLOGICAL MESHES 118
TABLE 28 MAJOR PRODUCTS IN THE BIOLOGICAL MESHES MARKET 119
TABLE 29 BIOLOGICAL MESHES MARKET, BY TYPE, 2019–2026 (USD MILLION) 119
TABLE 30 BIOLOGICAL MESHES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 119
7.3.2.1 Allografts 120
7.3.2.1.1 Advancements in deriving products from new allograft sources to drive market growth 120
TABLE 31 ALLOGRAFTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 121
7.3.2.2 Xenografts 121
7.3.2.2.1 Efficacy of xenografts against allografts is not proven 121
TABLE 32 XENOGRAFTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 122
7.4 HEMOSTATIC AGENTS 122
TABLE 33 MAJOR PRODUCTS IN THE HEMOSTATIC AGENTS MARKET 123
TABLE 34 BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE,
2019–2026 (USD MILLION) 123
TABLE 35 BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY COUNTRY,
2019–2026 (USD MILLION) 124
7.4.1 THROMBIN-BASED HEMOSTATIC AGENTS 124
7.4.1.1 Developments in recombinant thrombin products to support the growth of this market segment 124
TABLE 36 MAJOR PRODUCTS IN THE THROMBIN-BASED HEMOSTATIC AGENTS MARKET 125
TABLE 37 THROMBIN-BASED HEMOSTATIC AGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 125
7.4.2 OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATIC AGENTS 126
7.4.2.1 Vendors are expanding the availability of their ORC-based hemostatic agents across untapped markets in APAC 126
TABLE 38 MAJOR PRODUCTS IN THE OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATIC AGENTS MARKET 126
TABLE 39 OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATIC AGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 127
7.4.3 COMBINATION HEMOSTATIC AGENTS 127
7.4.3.1 Advancements in combination materials would contribute to the growth of this market segment 127
TABLE 40 MAJOR PRODUCTS IN THE COMBINATION HEMOSTATIC AGENTS MARKET 128
TABLE 41 COMBINATION HEMOSTATIC AGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 128
7.5 SURGICAL SEALANTS & ADHESIVES 129
TABLE 42 BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES,
BY TYPE, 2019–2026 (USD MILLION) 129
TABLE 43 BIOSURGERY MARKET FOR SURGICAL SEALANTS & ADHESIVES,
BY COUNTRY, 2019–2026 (USD MILLION) 130
7.5.1 NATURAL/BIOLOGICAL SEALANTS & ADHESIVES 130
7.5.1.1 Natural/biological sealants & adhesives, by type 130
TABLE 44 BIOSURGERY MARKET FOR NATURAL/BIOLOGICAL SEALANTS & ADHESIVES, BY TYPE, 2019–2026 (USD MILLION) 131
TABLE 45 BIOSURGERY MARKET FOR NATURAL/BIOLOGICAL SEALANTS & ADHESIVES, BY COUNTRY, 2019–2026 (USD MILLION) 131
7.5.1.1.1 Fibrin-based sealants & adhesives 132
7.5.1.1.1.1 Fibrin-based sealants & adhesives to dominate the market during the forecast period 132
TABLE 46 MAJOR PRODUCTS IN THE FIBRIN-BASED SEALANTS & ADHESIVES MARKET 132
TABLE 47 FIBRIN-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 133
7.5.1.1.2 Collagen-based sealants & adhesives 133
7.5.1.1.2.1 Low-cost and reduced risk of disease transmission are promoting the adoption of collagen-based sealants & adhesives 133
TABLE 48 MAJOR PRODUCTS IN THE COLLAGEN BASED-SEALANTS & ADHESIVES MARKET 134
TABLE 49 COLLAGEN-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 135
7.5.1.1.3 Gelatin-based sealants & adhesives 135
7.5.1.1.3.1 Combination products are creating promising growth opportunities for gelatin-based sealants & adhesives 135
TABLE 50 MAJOR PRODUCTS IN THE GELATIN BASED-SEALANTS & ADHESIVES MARKET 136
TABLE 51 GELATIN-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 136
7.5.1.1.4 Albumin-based sealants 137
7.5.1.1.4.1 Adoption of albumin-based sealants & adhesives is increasing in cardiovascular and cardiothoracic procedures 137
TABLE 52 MAJOR PRODUCTS IN THE ALBUMIN BASED-SEALANTS & ADHESIVES MARKET 137
TABLE 53 ALBUMIN-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 138
7.5.1.1.5 Other natural/biological sealants & adhesives 138
TABLE 54 OTHER NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 139
7.5.1.2 Natural/biological sealants & adhesives, by origin 140
TABLE 55 NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN,
2019–2026 (USD MILLION) 140
7.5.1.2.1 Animal-based sealants & adhesives 140
7.5.1.2.1.1 Animal-based sealants and adhesives are not intended for intravascular and cerebrovascular repair due to the risk of disease transfer 140
TABLE 56 ANIMAL-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 141
7.5.1.2.2 Human blood-based sealants & adhesives 141
7.5.1.2.2.1 Human blood-based sealants are finding significant applications in endovascular and laparoscopic vascular procedures 141
TABLE 57 HUMAN BLOOD-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 142
7.5.2 SYNTHETIC AND SEMI-SYNTHETIC SEALANTS & ADHESIVES 142
TABLE 58 SYNTHETIC AND SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 143
TABLE 59 SYNTHETIC AND SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 143
7.5.2.1 PEG hydrogel-based sealants & adhesives 144
7.5.2.1.1 Rapid sealing abilities of PEG hydrogels to drive their adoption in spinal surgeries 144
TABLE 60 MAJOR PRODUCTS IN THE PEG HYDROGEL-BASED SEALANTS & ADHESIVES MARKET 145
TABLE 61 PEG HYDROGEL-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 145
7.5.2.2 Cyanoacrylate-based sealants & adhesives 146
7.5.2.2.1 Cyanoacrylate-based sealants are preferred in dermatology and plastic surgeries 146
TABLE 62 MAJOR PRODUCTS IN THE CYANOACRYLATE-BASED SEALANTS & ADHESIVES MARKET 146
TABLE 63 CYANOACRYLATE-BASED SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 147
7.5.2.3 Urethane-based sealants & adhesives 147
7.5.2.3.1 Urethane-based sealants can be used across wet environments 147
TABLE 64 URETHANE-BASED SEALANTS & ADHESIVES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 148
7.5.2.4 Other synthetic and semi-synthetic sealants & adhesives 148
TABLE 65 MAJOR PRODUCTS IN THE OTHER SYNTHETIC AND SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET 149
TABLE 66 OTHER SYNTHETIC AND SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 149
7.6 ADHESION BARRIERS 150
TABLE 67 BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE,
2019–2026 (USD MILLION) 150
TABLE 68 BIOSURGERY MARKET FOR ADHESION BARRIERS, BY COUNTRY,
2019–2026 (USD MILLION) 150
7.6.1 SYNTHETIC ADHESION BARRIERS 151
TABLE 69 SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 70 SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 152
7.6.1.1 Hyaluronic acid-based adhesion barriers 152
7.6.1.1.1 Hyaluronic acid-based adhesion barriers dominate the synthetic adhesion barriers market 152
TABLE 71 MAJOR PRODUCTS IN THE HYALURONIC ACID-BASED ADHESION BARRIERS MARKET 153
TABLE 72 HYALURONIC ACID-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 153
7.6.1.2 Regenerated cellulose-based adhesion barriers 154
7.6.1.2.1 Regenerated cellulose-based adhesion barriers are finding increasing use in C-section surgeries 154
TABLE 73 MAJOR PRODUCTS IN THE REGENERATED CELLULOSE-BASED ADHESION BARRIERS MARKET 154
TABLE 74 REGENERATED CELLULOSE-BASED ADHESION BARRIERS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 155
7.6.1.3 PEG-based adhesion barriers 155
7.6.1.3.1 Demand for PEG-based adhesion barriers is driven
by the rising number of peritoneal and abdominal surgeries 155
TABLE 75 MAJOR PRODUCTS IN THE PEG-BASED ADHESION BARRIERS MARKET 155
TABLE 76 PEG-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 156
7.6.1.4 Other synthetic adhesion barriers 156
TABLE 77 MAJOR PRODUCTS IN THE OTHER SYNTHETIC ADHESION BARRIERS MARKET 157
TABLE 78 OTHER SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 157
7.6.2 NATURAL ADHESION BARRIERS 158
TABLE 79 NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 80 NATURAL ADHESION BARRIERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 158
7.6.2.1 Collagen and protein adhesion barriers 159
7.6.2.1.1 Collagen and protein adhesion barriers to dominate the natural adhesion barriers market during the forecast period 159
TABLE 81 MAJOR PRODUCTS IN THE COLLAGEN AND PROTEIN ADHESION BARRIERS MARKET 159
TABLE 82 COLLAGEN AND PROTEIN ADHESION BARRIERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 160
7.6.2.2 Fibrin-based adhesion barriers 160
7.6.2.2.1 Fibrin-based adhesion barriers are finding increasing applications in laparotomy procedures 160
TABLE 83 MAJOR PRODUCTS IN THE FIBRIN-BASED ADHESION BARRIERS MARKET 160
TABLE 84 FIBRIN-BASED ADHESION BARRIERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 161
7.7 STAPLE-LINE REINFORCEMENT AGENTS 161
7.7.1 RISING FOCUS ON SEALANTS AND HEMOSTATS MAY RESTRAIN THE GROWTH OF THIS MARKET 161
TABLE 85 MAJOR PRODUCTS IN THE STAPLE-LINE REINFORCEMENT AGENTS MARKET 162
TABLE 86 BIOSURGERY MARKET FOR STAPLE-LINE REINFORCEMENT AGENTS,
BY COUNTRY, 2019–2026 (USD MILLION) 162
8 BIOSURGERY MARKET, BY APPLICATION 163
8.1 INTRODUCTION 164
TABLE 87 BIOSURGERY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 164
8.2 ORTHOPEDIC SURGERY 164
8.2.1 ORTHOPEDIC SURGERY IS THE LARGEST APPLICATION SEGMENT FOR BIOSURGERY PRODUCTS 164
TABLE 88 BIOSURGERY MARKET FOR ORTHOPEDIC SURGERY, BY COUNTRY,
2019–2026 (USD MILLION) 165
8.3 GENERAL SURGERY 166
8.3.1 INCREASING NUMBER OF HERNIA REPAIR PROCEDURES TO DRIVE
THE GROWTH OF THIS APPLICATION SEGMENT 166
TABLE 89 BIOSURGERY MARKET FOR GENERAL SURGERY, BY COUNTRY,
2019–2026 (USD MILLION) 167
8.4 NEUROLOGICAL SURGERY 167
8.4.1 GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT 167
TABLE 90 BIOSURGERY MARKET FOR NEUROLOGICAL SURGERY, BY COUNTRY,
2019–2026 (USD MILLION) 168
8.5 CARDIOVASCULAR SURGERY 169
8.5.1 BIOSURGERY PRODUCTS ARE INCREASINGLY REPLACING CONVENTIONAL SUTURE-BASED METHODS IN CARDIOVASCULAR PROCEDURES 169
TABLE 91 BIOSURGERY MARKET FOR CARDIOVASCULAR SURGERY, BY COUNTRY, 2019–2026 (USD MILLION) 170
8.6 RECONSTRUCTIVE SURGERY 170
8.6.1 SOFT-TISSUE ATTACHMENT PRODUCTS ARE FINDING INCREASING USE IN BREAST AUGMENTATION AND RECONSTRUCTIVE PROCEDURES 170
TABLE 92 BIOSURGERY MARKET FOR RECONSTRUCTIVE SURGERY, BY COUNTRY, 2019–2026 (USD MILLION) 171
8.7 GYNECOLOGICAL SURGERY 172
8.7.1 BIOSURGERY PRODUCTS ARE OFFERING PROMISING POTENTIAL IN C-SECTION SURGERIES 172
TABLE 93 C-SECTION SURGERIES PER 1,000 BIRTHS (2018 OR LATEST AVAILABLE) 172
TABLE 94 BIOSURGERY MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY,
2019–2026 (USD MILLION) 173
8.8 UROLOGICAL SURGERY 173
8.8.1 USE OF BIOSURGERY PRODUCTS IN COMPLEX RECONSTRUCTIVE UROLOGICAL SURGERIES TO STIMULATE SEGMENT GROWTH 173
TABLE 95 BIOSURGERY MARKET FOR UROLOGICAL SURGERY, BY COUNTRY,
2019–2026 (USD MILLION) 174
8.9 THORACIC SURGERY 175
8.9.1 GROWTH IN THIS APPLICATION SEGMENT IS DRIVEN BY THE INCREASING INCIDENCE OF PULMONARY DISEASES AND LUNG CANCER 175
TABLE 96 BIOSURGERY MARKET FOR THORACIC SURGERY, BY COUNTRY,
2019–2026 (USD MILLION) 175
8.10 OTHER APPLICATIONS 176
TABLE 97 BIOSURGERY MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2019–2026 (USD MILLION) 177
9 BIOSURGERY MARKET, BY END USER 178
9.1 INTRODUCTION 179
TABLE 98 BIOSURGERY MARKET, BY END USER, 2019–2026 (USD MILLION) 179
9.2 HOSPITALS 179
9.2.1 HOSPITALS ARE THE LARGEST END USERS OF BIOSURGERY PRODUCTS 179
TABLE 99 BIOSURGERY MARKET FOR HOSPITALS, BY COUNTRY,
2019–2026 (USD MILLION) 180
9.3 CLINICS 181
9.3.1 QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAYS ARE ADVANTAGES OFFERED BY CLINICS OVER HOSPITALS 181
TABLE 100 BIOSURGERY MARKET FOR CLINICS, BY COUNTRY,
2019–2026 (USD MILLION) 182
9.4 OTHER END USERS 182
TABLE 101 BIOSURGERY MARKET FOR OTHER END USERS, BY COUNTRY,
2019–2026 (USD MILLION) 183
10 BIOSURGERY MARKET, BY REGION 184
10.1 INTRODUCTION 185
FIGURE 27 GEOGRAPHIC SNAPSHOT: MARKETS IN ASIA PACIFIC ARE EMERGING HOTSPOTS 185
TABLE 102 BIOSURGERY MARKET, BY REGION, 2019–2026 (USD MILLION) 186
10.2 NORTH AMERICA 187
FIGURE 28 NORTH AMERICA: BIOSURGERY MARKET SNAPSHOT 187
TABLE 103 NORTH AMERICA: BIOSURGERY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 188
TABLE 104 NORTH AMERICA: BIOSURGERY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 188
TABLE 105 NORTH AMERICA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 188
TABLE 106 NORTH AMERICA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 189
TABLE 107 NORTH AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE,
2019–2026 (USD MILLION) 189
TABLE 108 NORTH AMERICA: HEMOSTATIC AGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 189
TABLE 109 NORTH AMERICA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 110 NORTH AMERICA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 111 NORTH AMERICA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019–2026 (USD MILLION) 190
TABLE 112 NORTH AMERICA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 113 NORTH AMERICA: ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
TABLE 114 NORTH AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 115 NORTH AMERICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
TABLE 116 NORTH AMERICA: BIOSURGERY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 192
TABLE 117 NORTH AMERICA: BIOSURGERY MARKET, BY END USER,
2019–2026 (USD MILLION) 192
10.2.1 US 192
10.2.1.1 US to dominate the North American biosurgery market during the forecast period 192
TABLE 118 US: BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 193
TABLE 119 US: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 120 US: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 121 US: BIOLOGICAL MESHES MARKET, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 122 US: HEMOSTATIC AGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 123 US: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
TABLE 124 US: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 195
TABLE 125 US: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY ORIGIN, 2019–2026 (USD MILLION) 195
TABLE 126 US: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 127 US: ADHESION BARRIERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 128 US: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 196
TABLE 129 US: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 130 US: BIOSURGERY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 197
TABLE 131 US: BIOSURGERY MARKET, BY END USER, 2019–2026 (USD MILLION) 197
10.2.2 CANADA 198
10.2.2.1 Growing geriatric population and the increasing volume of surgeries to drive the demand for biosurgery products in Canada 198
TABLE 132 CANADA: BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 198
TABLE 133 CANADA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 134 CANADA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 135 CANADA: BIOLOGICAL MESHES MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 136 CANADA: HEMOSTATIC AGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 137 CANADA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 200
TABLE 138 CANADA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 139 CANADA: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY ORIGIN, 2019–2026 (USD MILLION) 200
TABLE 140 CANADA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 201
TABLE 141 CANADA: ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 201
TABLE 142 CANADA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 201
TABLE 143 CANADA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 202
TABLE 144 CANADA: BIOSURGERY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 202
TABLE 145 CANADA: BIOSURGERY MARKET, BY END USER, 2019–2026 (USD MILLION) 202
10.3 EUROPE 203
TABLE 146 EUROPE: BIOSURGERY MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 203
TABLE 147 EUROPE: BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 204
TABLE 148 EUROPE: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 204
TABLE 149 EUROPE: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 204
TABLE 150 EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE,
2019–2026 (USD MILLION) 205
TABLE 151 EUROPE: HEMOSTATIC AGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 205
TABLE 152 EUROPE: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 205
TABLE 153 EUROPE: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 154 EUROPE: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY ORIGIN, 2019–2026 (USD MILLION) 206
TABLE 155 EUROPE: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 156 EUROPE: ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 207
TABLE 157 EUROPE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 207
TABLE 158 EUROPE: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 207
TABLE 159 EUROPE: BIOSURGERY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 208
TABLE 160 EUROPE: BIOSURGERY MARKET, BY END USER, 2019–2026 (USD MILLION) 208
10.3.1 GERMANY 208
10.3.1.1 Germany dominated the European biosurgery market in 2020 208
TABLE 161 GERMANY: BIOSURGERY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 209
TABLE 162 GERMANY: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE,
2019–2026 (USD MILLION) 209
TABLE 163 GERMANY: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 209
TABLE 164 GERMANY: BIOLOGICAL MESHES MARKET, BY TYPE,
2019–2026 (USD MILLION) 210
TABLE 165 GERMANY: HEMOSTATIC AGENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 210
TABLE 166 GERMANY: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE,
2019–2026 (USD MILLION) 210
TABLE 167 GERMANY: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 168 GERMANY: NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET,
BY ORIGIN, 2019–2026 (USD MILLION) 211
TABLE 169 GERMANY: SYNTHETIC & SEMI-SYNTHETIC SEALANTS & ADHESIVES MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 170 GERMANY: ADHESION BARRIERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 212
TABL